Signifier® Medical Technologies to host webinar on precision medicine for obstructive sleep apnoea and emerging technologies

Live Webinar: Thursday 25th June 4pm PDT (26th June 9am AEST, 26th June 12am BST)– FREE

sleep apnoea

LONDON, 9th June 2020

Signifier Medical Technologies today announced that it will host a live webinar on Thursday 25th June 4pm PDT (26th June 9am AEST, 26th June 12am BST) to learn about the latest advances in the management of sleep disordered breathing and emerging new technologies in the field of sleep medicine.

It is thought that up to 70m people in the USA, and 6m people in Australia have sleep disordered breathing, therefore, it is important for health care professionals to be able to offer their patients the latest advances in sleep medicine.

The webinar will feature three experts on sleep disordered breathing, Prof. Dr. Peter Cistulli – Clinical Director of the Sleep Medicine Program at Royal North Shore Hospital University of Sydney and Res Med Chair in Sleep Medicine, Prof. Dr. Malhotra – Research Chief in Pulmonary, critical care and sleep medicine at UC San Diego. He is Peter C. Farrell Presidential chair and Professor in Respiratory Medicine at UCSD, and Prof. Dr. Anshul Sama (FRCS), Founder and Chief Medical Officer of Signifier Medical Technologies and Ear, Nose and Throat Surgeon at the University of Nottingham.

The speakers will cover the following topics in this free webinar:

  • Obstructive Sleep Apnoea: need for bespoke management
  • Emerging technologies and future trends in management of OSA
  • Neuromuscular electrical stimulation: the technology and results

The webinar will include a Q&A session with the speakers. Please register HERE.

About Signifier Medical Technologies

Signifier Medical Technologies, previously known as Snoozeal®, is a medical technology company focused on the development and commercialization of innovative and non-invasive solutions for patients with snoring and sleep disordered breathing conditions.

Signifier’s proprietary therapy is the first and only day time genioglossal muscle-neurostimulation technology, with proven clinical data from prestigious and well-recognised universities and academic institutions, that provides a safe and effective treatment for its patients. 1, 2

References

  1. A.Sama et al. Daytime Intraoral Neuromuscular stimulation with Snoozeal® for treatment of Snoring and Mild Sleep Apnea. CHEST Annual Meeting Notes, 2018
  2. E.Wessoleck et al. Intraoral electrical muscle stimulation in the treatment of snoring. Somnologie (Berl). 2018; 22(Suppl 2): 47–52.

For media enquiries:
info@signifiermedical.com
+44 (0) 207 096 0586

Take your first steps towards a restful night’s sleep today